Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Investment Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Biotech Growth Trust PLC/The

+ Add to Watchlist

BIOG:LN

808.0000 GBp 2.5000 0.31%

As of 11:35:17 ET on 04/24/2015.

Snapshot for Biotech Growth Trust PLC/The (BIOG)

Open: 810.0000 High - Low: 820.0000 - 798.5000 Primary Exchange: London
Volume: 129,341 52-Week Range: 425.0000 - 874.5000 Beta vs NBI: 0.9246

ETF Chart for BIOG

No chart data available.
  • BIOG:LN 808.0000
  • 1D
  • 1M
  • 1Y
810.5000
Interactive BIOG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BIOG

The Biotech Growth Trust PLC is a closed-end fund incorporated in the United Kingdom. The aim of the Fund is to achieve capital appreciation through investment in the worldwide biotechnology industry principally by investing in emerging biotechnology companies.

Inception Date: 1997-06-23 Telephone: +44-20-3008-4910
Managers: RICHARD D KLEMM / GEOFFREY C HSU
Web Site: www.biotechgt.com

Fundamentals for BIOG

NAV (on 2015-04-23) 880.9800
Assets (M) (on 2004-09-30) 28.4000
Shares out (M) 63.53
Market Cap (M) 513.35
% Premium -8.00
Average 52-Week % Premium -5.0612
Fund Leveraged N

Dividends for BIOG

Dividend Type Discontinued
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -%

Performance for BIOG

1-Month -0.55% 1-Year +83.17%
3-Month +4.94% 3-Year +47.85%
Year To Date +19.17% 5-Year +37.02%
Expense Ratio 1.20

Top Fund Holdings for BIOG

Filing Date: 12/31/2014
Name Position Value % of Total
Biogen Inc 222,700 48,494,828 11.189%
Celgene Corp 594,000 42,613,334 9.832%
Amgen Inc 407,000 41,575,733 9.592%
Gilead Sciences Inc 590,300 35,681,114 8.232%
Vertex Pharmaceuticals Inc 372,000 28,340,472 6.539%
Illumina Inc 206,300 24,415,971 5.633%
Alexion Pharmaceuticals Inc 198,000 23,494,604 5.421%
Regeneron Pharmaceuticals Inc 75,000 19,723,906 4.551%
Incyte Corp 384,500 18,018,545 4.157%
Medivation Inc 224,000 14,309,854 3.302%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil